Clinical Trial Update: A Study of Evacetrapib (LY2484595) in Combination With Atorvastatin in Japanese Participants With Primary Hypercholesterolemia [Phase 3]

View source ↗

Summary

Phase 3 trial of Evacetrapib (LY2484595) with atorvastatin in Japanese participants with primary hypercholesterolemia was terminated; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Evacetrapib
• atorvastatin (atorvastatin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Hypercholesterolemia | Phase 3 | Status: TERMINATED | Results posted: 2018-10-09